IRF4 dysregulation in chronic myelomonocytic leukemia: another brick in the wall of myelodysplastic/myeloproliferative neoplasms-Reference-Cited by-同舟云学术

IRF4 dysregulation in chronic myelomonocytic leukemia: another brick in the wall of myelodysplastic/myeloproliferative neoplasms

Published:2024-08-15 Issue: Volume: Page:
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Tarantini Francesco,Cumbo Cosimo,Parciante Elisa,Anelli Luisa,Zagaria Antonella,Coccaro Nicoletta,Tota Giuseppina,Redavid Immacolata,Conserva Maria Rosa,Minervini Angela,Minervini Crescenzio Francesco,Cellamare Angelo,Casieri Paola,Nuzzi Maria Cristina,Ricco Alessandra,Specchia Giorgina,Musto Pellegrino,Albano Francesco

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00277-024-05938-y.pdf

Reference8 articles.

1. Chan O, Renneville A, Padron E (2021) Chronic myelomonocytic leukemia diagnosis and management. Leukemia 35:1552–1562. https://doi.org/10.1038/s41375-021-01207-3

2. Khoury JD, Solary E, Abla O et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia 36:1703–1719. https://doi.org/10.1038/s41375-022-01613-1

3. Arber DA, Orazi A, Hasserjian RP et al (2022) International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140:1200–1228. https://doi.org/10.1182/blood.2022015850

4. Patnaik MM (2022) How I diagnose and treat chronic myelomonocytic leukemia. Haematologica 107:1503–1517. https://doi.org/10.3324/haematol.2021.279500

5. Elmariah H, DeZern AE (2019) Chronic myelomonocytic leukemia: 2018 update to prognosis and treatment. Curr Hematol Malig Rep 14:154–163. https://doi.org/10.1007/s11899-019-00509-9